Virology

Art, science of developing formulations for vaginal microbicides presented

Published in Women's Health Weekly, June 12th, 2003

Getting a false negative because of an incorrect HIV formulation was among the many topics discussed by Gordon Dow at a presentation on vaginal topical microbicide development.

His program was hosted by the National Institute of Allergy and Infectious Diseases (NIAID) in association with the U.S. National Institutes of Health (NIH). Dow's presentation was part of "Microbicides 2003," a 4-day workshop held in March at the Sheraton Four Points in Silver Spring, Maryland, by members of the Alliance for Microbicide Development. Highlights of this forum included recent scientific advancements in topical microbicides for HIV and other STDs; collaboration building among...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (2003-06-12)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry